A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past […]
Once again, the Scientific American WorldView project continues to measure global biotechnology innovation. I had the pleasure of serving as
Scientific American WorldView 2010: Measuring global biotechnology innovation Read Post »
As promised, I have posted my observations from the 2009 Kyoto Prize. I had an opportunity to interact with each
Case studies in innovation: What enables outstanding achievements? Read Post »
Moira Gunn’s Tech Nation interview of Jeremy Abbate and I on the Scientific American worldView project is now available at
Scientific American worldView Interview available Read Post »
At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me
Is the practice of medicine impeding medical innovation? Read Post »
With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the
Biotechnology Industry Organization CEO Jim Greenwood appeared on CNBC’s SquawkBox defending the case for data exclusivity protection for novel biologic
Jim Greenwood on Data Exclusivity and Healthcare Innovation Read Post »
My most recent editorial in the Journal of Commercial Biotechnology, “The impact of the global financial crisis on biotechnology development,”
The impact of the global financial crisis on biotechnology development Read Post »
Here is a recent keynote I gave for the Delaware Valley Innovation Network. The group is working on coordinating the
After months of preparation, the Scientific American worldVIEW project has launched. I had the pleasure of serving as lead editorial
Scientific American WorldVIEW: Measuring Global Biotechnology Innovation Read Post »